Does surgical stress cause tumor metastasis?
1Kodama Research Institute of Preventive Medicine, Laboratory of Service Section, Nagoya, Japan.
Anticancer Research
|September 1, 1992
Summary
Surgical stress can worsen cancer prognosis by increasing glucocorticoids, which promote tumor metastasis. This study found glucocorticoid excess post-surgery and demonstrated its role in facilitating lung metastasis in mice.
Area of Science:
- Oncology
- Endocrinology
- Cancer Metastasis Research
Background:
- Surgical stress is a potential factor influencing cancer patient prognosis.
- The hypothesis posits that surgical stress elevates glucocorticoid activity, promoting hematogenous tumor metastasis.
Purpose of the Study:
- To investigate the link between surgical stress, glucocorticoid activity, and tumor metastasis.
- To determine if glucocorticoid excess in cervical cancer patients correlates with metastasis.
- To assess the effect of glucocorticoid excess on tumor metastasis in a murine model.
Main Methods:
- Measured glucocorticosteroid levels in cervical cancer patients undergoing radical surgery.
- Utilized a mouse model with inoculated Ehrlich ascites tumor cells to study metastasis.
- Administered hydrocortisone to mice as a proxy for surgical stress-induced glucocorticoid increase.
- Evaluated the efficacy of cyclophosphamide as adjuvant chemotherapy in conditioned mice.
Main Results:
- Glucocorticoid excess was observed in cancer patients during early postoperative recovery.
- Hydrocortisone pretreatment facilitated lung metastasis of tumor cells in mice.
- Glucocorticoids induced lung capillary constriction and tumor cell surface microvillus growth, aiding metastasis.
- Cyclophosphamide demonstrated efficacy in retarding or arresting tumor metastasis in glucocorticoid-conditioned mice.
Conclusions:
- Surgical stress-induced glucocorticoid excess may enhance blood-borne tumor cell metastasis.
- Glucocorticoid actions on capillary lumen and tumor cell morphology contribute to metastasis.
- Adjuvant chemotherapy with cyclophosphamide may counteract postoperative micrometastasis in the context of glucocorticoid activity.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...


